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respectively, reverted anti-apoptotic or anti-senescent Vit.D 
properties. SirT1 protein expression levels were up-regulated 
by Vit.D. ERKs inhibition blocked Vit.D-induced SirT1 protein 
up-regulation in proliferating cells. In quiescent HUVEC cells, 
p38 inhibition counteracted the IR-induced SirT1 protein 
down-regulation, while MKK6 transfection abrogated the 
Vit.D positive effects on SirT1 protein levels after irradiation. 
SirT1 inhibition by sirtinol blocked the Vit.D radioprotective 
effects. 
 
Conclusion: Vit.D protects HUVEC from IR induced/oxidative 
stress by positively regulating the MAPKs/SirT1 axis. 
 
EP-2042  
Meta-analysis: can amifostine reduce chemoradiotherapy 
and radiotherapy toxicity in advanced NSCLC? 
A. Devine
1Applied Radiation Therapy Trinity, Discipline of Radiation 
Therapy, Dublin, Ireland Republic of 
1, L. Marignol1 
 
Purpose or Objective: Trials of amifostine in patients with 
advanced non-small cell lung cancer (NSCLC) receiving 
chemoradiotherapy (CRT) or radiotherapy (RT) alone report 
varying treatment-related toxicity. A review and meta-
analysis was conducted to examine amifostine’s effect on 
toxicity and efficacy of CRT or RT alone in such patients. 
 
Material and Methods: Searches of electronic databases 
yielded 16 eligible trials comprising 1057 patients. Data 
extracted from randomised and non-randomised trials were 
compiled in a review; results of randomised trials were 
pooled and using meta-analyses to estimate the effect of 
amifostine on treatment toxicity and efficacy.  
 
Results: Amifostine reduced the risk of >Grade 2 acute 
oesophagitis by 26% (risk ratio [RR], 0.74; 95% confidence 
interval [CI], 0.65-0.86; p<0.0001) and the risk of acute 
pulmonary toxicity by 44% (RR, 0.56; 95%CI, 0.41-0.75; 
p=0.0001). Amifostine did not alter risk of late pulmonary 
toxicity (RR, 0.84; 95% CI, 0.65-1.08; p=0.17). Risk of 
complete response was unchanged (RR, 1.64; 95% CI, 0.99-
2.73; p=0.06), partial response was unchanged (RR, 0.92; 95% 
CI, 0.73-1.16; p=0.48). Statistical heterogeneity was high for 
toxicity but low for response. Non-randomised trials reported 
varying incidence of toxicities and survival/response. Studies 
were medium-high quality. 
 
Conclusion: Statistical heterogeneity casts doubt over 
amifostine’s efficacy in this setting, despite evidence of 
decreased incidence of acute oesophageal and pulmonary 
toxicity but not late pulmonary toxicity. Amifostine did not 
compromise CRT or RT efficacy.  
 
EP-2043  
The ANDANTE project: a re-evaluation of the risk from 
scattered neutrons during proton therapy 
A. Ottolenghi
1Universita degli Studi di Pavia, Dipartimento di Fisica, 
Pavia, Italy 
1, V. Smyth1, K. Trott1 
 
Purpose or Objective: It is well known that proton therapy 
generates a small but significant exposure to scattered 
neutrons. The success of paediatric proton treatments leads 
to a concern about second cancers arising in later life from 
the neutron exposure. However there are difficulties involved 
with estimating the risk from exposure to neutrons. The usual 
approach is through the concept of relative biological 
effectiveness (RBE) of neutrons compared to photons, since 
the risk from photon exposure is much better known (ICRP 
Publication 103. Ann. ICRP 37 (2-4), 2007) The RBE for 
neutrons has been evaluated using cellular and animal 
models. But this causes uncertainty when applying the 
method to humans. The ANDANTE project 
(http://www.andanteproject.eu/) has investigated the 
relative risk of cancer from neutrons compared to photons in 
the context of proton therapy, using three different 
disciplines in parallel.  
 
Material and Methods: Physics: Charged particle spectra 
generated by both neutron and photon beams were 
characterised using Monte Carlo simulation and 
measurements. A track structure model was used to model 
the formation of complex lesions in DNA from the different 
spectra as an indicator of relative likelihood of cancer 
induction. A method was developed for reconstructing the 
scattered neutron doses outside the treatment volume during 
proton therapy, using available clinical data, in order to be 
able to predict second cancer risks. Stem cell radiobiology: 
Stem cells from thyroid, salivary gland, and breast tissue 
were given well characterised exposures to both broad- and 
narrow-spectrum neutron beams, and to 200 kV X-rays. The 
relative risk of damage from neutrons compared to photons 
was estimated using a number of endpoints. Part of the cell 
population was transplanted into mice. Detailed 
histopathological and molecular investigations were 
performed looking for pre-malignant lesions and signs of 
malignancy. Epidemiology: The results from the track 
structure modelling and stem cell experiments were 
combined to generate a relative risk model. Dose 
reconstruction and data analysis tools were developed for a 
multi-centre prospective epidemiological study using data 
from paediatric proton therapy treatments, which will test 
the relative risk model. The project has made initial plans for 
the study as a collaboration between centres in Europe and 
the USA. 
 
Results: The track structure model reproduced the peak in 
relative risk between neutrons and photons at a neutron 
energy of around 1 MeV, similar to the ICRP model. The stem 
cell experiments successfully demonstrated a new 
methodology, but did not provide conclusive evidence to 
contradict the ICRP model. The feasibility of a prospective 
epidemiological study was demonstrated. 
 
Conclusion: The results from the ANDANTE project do not 
contradict ICRP. In the longer term, the prospective study 
will provide greater certainty on the RBE for neutrons and 
how this applies to humans receiving proton therapy. 
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Purpose or Objective: Radiation-induced fibrosis is a delayed 
complication of radiotherapy often associated with chronic 
inflammatory process and macrophage infiltration. 
Nowadays, macrophages are suggested to be important 
cellular contributors to fibrogenic process, but their 
implication in the context of RIF is not well known. 
 
Material and Methods: To investigate the role of 
macrophages in RIF we have used a classical experimental 
model of lung fibrosis developed in C57Bl/6 mice after 16Gy 
thorax-IR. We then profiled both alveolar macrophages (AM) 
and interstitial macrophages (IM) during the various steps of 
the fibrogenic process. 
 
Results: We confirmed the fact that total lung irradiation at 
16Gy (IR) induces an interstitial fibrosis associated with 
delayed recruitment of pulmonary macrophages.  
We found a transient depletion of AM associated with 
cytokine secretion during the acute post-IR phase (15 days), 
followed by an active repopulation and an enhanced number 
of AM during the late post-IR phase (20 weeks). Interestingly, 
AM were mostly recruited from the bone marrow and exhibit 
a hybrid polarization (M1/M2) associated with up-regulation 
of Th1 and Th2 cytokines. The number of M2-polarized IM 
significantly increased during the late time points after 
irradiation and a down-regulation of Th1 cytokine was 
measured in tissue lysate. These results suggest a differential 
contribution of hybrid AM vs M2-IM to fibrogenesis. 
Interestingly, in contrast to activated hybrid AM, activated 
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M2-IM were able to induce fibroblast activation in vitro 
mediated by an enhanced TGF-β1 expression suggesting a 
profibrotic role of M2-IM. Specific depletion of hybrid AM 
using intranasal administration of clodrosome increased 
radiation-induced fibrosis score and enhanced M2-IM 
infiltration suggesting a protective role of hybrid AM. 
 
Conclusion: These present study shows a dual and opposite 
contribution of alevolar versus intertitial macrophages in 
radiation-induced fibrosis and identify M2-IM as a potential 
therapeutic target to treat radiation-induced fibrosis. 
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Purpose or Objective: Adverse events in normal tissues 
during and after a course of cancer radiation treatment are 
one of the most pressing problems of modern radiation 
oncology. From among numerous works in this field, there 
are but a few concerned with the radiation-induced 
alterations of collagen, the processes of its degradation and 
subsequent remodeling. A new imaging technique – 
multiphoton microscopy (MPM) allows studying tissue collagen 
state on fibers and bundles level without additional staining 
due to second harmonic generation (SHG) phenomenon. The 
method has the key advantage of a potential in vivo 
application. This study’s objective was in vivo evaluation of 
changes occurring at rat’s skin collagen upon the exposure of 
conventional irradiation. 
 
Material and Methods: Rat’s ear was chosen as a model for 
detecting collagen changes. Experiments were carried out 
under Nizhny Novgorod Medical Academy ethical committee 
permission. Three male animals, 2 months old at the time of 
experiment, were used. Rat’s ear was irradiated under 
general anesthesia (Zoletyl, 50 mg/kg, Virbac Sante Animale, 
France) by a Co60 unit Terabalt (UJP, Czech Republic) by a 
local field with single dose of 2 Gy up to the total dose of 24 
Gy. The 3D imaging of collagen structure was performed by 
MPTflex (JenaLab, Germany) – a system for in vivo optical 
biopsies based on near infrared femtosecond laser 
technology. MPM imaging was carried out two times a week 
beginning from the first day of irradiation and once a week 
for three months after its completion. Cross-sectional images 
were obtained beginning from the horny layer with the step 
of 5 µm up to the total depth of 100 µm. Excitation was 
implemented with a pulsed (200 fs) titanium-sapphire laser at 
a wavelength of 740 nm and a pulse repetition frequency of 
80 MHz; SHG collagen imaging was performed at 373-387 nm. 
Cross-sectional images of 512х512 pixels were obtained; the 
field size was 130х130 µm. Numerical processing of the 
images was performed by ImageJ program. Mean 
fluorescence intensity and its standard deviation was 
calculated for all images. Coefficient S (a ratio of standard 
deviation/mean fluorescence intensity) was used for 
evaluation of collagen state.  
 
 
 
 
 
 
 
 
 
 
 
Results: 
 
 
Visual evaluation of MPM images demonstrated no noticeable 
changes of collagen packing and structure independent on 
the dose and time from radiation beginning (Fig.1, a, b, c). 
Numerical processing revealed subtle, but clear differences 
of coefficient S between intact and irradiated collagen. After 
radiation beginning, a decrease of magnitude of coefficient S 
and the decrease of title angle of the graph was observed 
(Fig.1 d). In a month after radiation completion, a magnitude 
remained decreased, but tilt angle of the graph returned to 
the initial level (Fig.1 d). 
 
Conclusion: Numerical processing of MPM-images 
demonstrated changes of optical properties of collagen upon 
expose of clinically relevant doses of gamma-irradiation. The 
radiobiological interpretation of these changes require 
further study. 
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Purpose or Objective: Oral mucositis is the most frequently 
occurring, dose limiting early adverse event of head-and-neck 
cancer radio(chemo)therapy. The purpose of the present 
study was to quantify the mucoprotective effect of dermatan 
sulfate (DS), and to characterise the associated changes in 
the expression of markers for epithelial proliferation, cell 
junctions, inflammation and hypoxia.  
 
Material and Methods: The study comprises a functional and 
a histological arm. For the functional investigations, mice 
were irradiated with 5x3 Gy/week over one (days 0-4) or two 
weeks (days 0-4, 7-11). Each protocol was concluded by 
irradiation with graded top-up doses (day 7/14), to generate 
complete dose-effect curves. Daily doses of DS (4 mg/kg 
subcutaneously) were applied over varying time intervals. 
Mucosal ulceration, was analysed as clinically relevant 
endpoint during the functional studies. In the histological 
study, groups of three mice were sacrificed every second 
day, the tongues were excised and subjected to 
histological/immunohistochemical processing.  
 
Results: DS significantly increased isoeffective doses for the 
induction of oral mucositis in almost all protocols, and 
